Hitachi has signed an agreement with the government of Saskatchewan in Canada for the joint research and development of nuclear medicine technology.
Saskatchewan also signed a deal with Hitachi-GE Nuclear Energy, GE Hitachi Nuclear Energy Americas, and Global Nuclear Fuel -- Americas to discuss the potential of working together on future nuclear R&D projects, including nuclear safety, uranium recovery, and the design of small modular reactor technologies.
Saskatchewan and four other entities will fund $10 million Canadian ($10.2 million U.S.) for the two agreements to facilitate and support research collaborations in nuclear medicine, materials science, nuclear safety, and small reactor design.
Earlier this year, the Saskatchewan government invested $30 million ($30.6 million U.S.) to establish a new center for research in nuclear medicine and materials science, $17 million ($17.3 million U.S.) to create a Centre for Innovation in Cyclotron Science, $12 million ($12.2 million U.S.) to support innovative research in the production of medical isotopes, and $10.1 million ($10.3 million U.S.) for the development of Saskatchewan's first proton beam therapy/PET facility for the diagnosis and treatment of cancer and heart disease at the University of Saskatchewan.
